Trexquant Investment’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.79M | Buy |
192,068
+56,049
| +41% | +$2.28M | 0.05% | 528 |
|
|
2025
Q4 | $5.52M | Buy |
+136,019
| New | +$5.92M | 0.05% | 543 |
|
|
2025
Q3 | – | Sell |
-32,662
| Closed | -$1.7M | – | 1635 |
|
|
2025
Q2 | $1.7M | Buy |
+32,662
| New | +$1.79M | 0.02% | 937 |
|
|
2025
Q1 | – | Sell |
-38,644
| Closed | -$2.64M | – | 1595 |
|
|
2024
Q4 | $2.64M | Buy |
+38,644
| New | +$2.69M | 0.03% | 765 |
|
|
2024
Q3 | – | Sell |
-40,772
| Closed | -$2.83M | – | 1566 |
|
|
2024
Q2 | $2.83M | Sell |
40,772
-38,163
| -48% | -$2.78M | 0.04% | 608 |
|
|
2024
Q1 | $6.32M | Buy |
78,935
+43,914
| +125% | +$3.91M | 0.13% | 228 |
|
|
2023
Q4 | $3.84M | Buy |
35,021
+9,891
| +39% | +$1.02M | 0.09% | 332 |
|
|
2023
Q3 | $2.53M | Buy |
+25,130
| New | +$2.89M | 0.06% | 421 |
|
|
2022
Q2 | – | Sell |
-2,119
| Closed | -$315K | – | 1563 |
|
|
2022
Q1 | $315K | Buy |
+2,119
| New | +$296K | 0.01% | 976 |
|
|
2021
Q3 | – | Sell |
-1,661
| Closed | -$228K | – | 1184 |
|
|
2021
Q2 | $228K | Buy |
+1,661
| New | +$227K | 0.02% | 843 |
|
|
2021
Q1 | – | Sell |
-4,942
| Closed | -$554K | – | 1160 |
|
|
2020
Q4 | $554K | Buy |
+4,942
| New | +$468K | 0.06% | 406 |
|
|
2020
Q3 | – | Sell |
-7,647
| Closed | -$551K | – | 1232 |
|
|
2020
Q2 | $551K | Sell |
7,647
-14,633
| -66% | -$1.02M | 0.04% | 643 |
|
|
2020
Q1 | $1.28M | Buy |
22,280
+17,318
| +349% | +$1.6M | 0.09% | 334 |
|
|
2019
Q4 | $555K | Buy |
+4,962
| New | +$529K | 0.03% | 525 |
|
|
2019
Q2 | – | Sell |
-6,860
| Closed | -$571K | – | 853 |
|
|
2019
Q1 | $571K | Buy |
+6,860
| New | +$498K | 0.04% | 551 |
|
|
2018
Q4 | – | Sell |
-2,890
| Closed | -$229K | – | 1063 |
|
|
2018
Q3 | $229K | Buy |
+2,890
| New | +$224K | 0.02% | 779 |
|
|
2018
Q1 | – | Sell |
-7,610
| Closed | -$388K | – | 1112 |
|
|
2017
Q4 | $388K | Buy |
+7,610
| New | +$396K | 0.04% | 619 |
|
|
2017
Q2 | – | Sell |
-16,900
| Closed | -$751K | – | 832 |
|
|
2017
Q1 | $751K | Buy |
+16,900
| New | +$727K | 0.1% | 374 |
|
|
2016
Q2 | – | Sell |
-7,213
| Closed | -$303K | – | 901 |
|
|
2016
Q1 | $303K | Sell |
7,213
-2,287
| -24% | -$89.8K | 0.04% | 730 |
|
|
2015
Q4 | $418K | Buy |
9,500
+2,900
| +44% | +$126K | 0.04% | 741 |
|
|
2015
Q3 | $315K | Buy |
+6,600
| New | +$362K | 0.03% | 865 |
|
Other funds holding CNMD
VPM
VCM
CB
Trexquant Investment's CNMD Position: Q1 2026 in Review
Trexquant Investment increased its CONMED (CNMD) stake by 41% in Q1 2026, buying an estimated $2.28M and bringing the position to 192,068 shares worth $6.79M. The position accounts for 0.05% of the portfolio, ranked #528.
Trexquant Investment first reported a position in CNMD in Q3 2015 and has held it in 21 quarters since. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Trexquant Investment held 192,068 shares of CONMED worth $6.79M as of Q1 2026.
- Trexquant Investment bought 56,049 CONMED shares in Q1 2026, an estimated $2.28M.
- CONMED made up 0.05% of Trexquant Investment's portfolio in Q1 2026, its #528 holding.
- Trexquant Investment first reported a position in CONMED in Q3 2015 and has held it in 21 quarters since.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.